Oct 19, 2022, 15:52 PM by

Form Bio is a new, cutting-edge research and discovery platform for individuals and enterprises in life sciences. With the most accessible, comprehensive and collaborative platform in the field, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. Form Bio was developed within Colossal Biosciences and co-founded by Ben Lamm, Andrew Busey, and Kent Wakeford. For more information on Form Bio, please visit www.formbio.com

Oct 19, 2022, 15:52 PM by

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).

Oct 19, 2022, 15:52 PM by

Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide.

Oct 19, 2022, 15:52 PM by

New functionality added to advanced dossier management solution to bring greater efficiencies to eCTD compliance

Oct 19, 2022, 15:52 PM by

A ribbon-cutting ceremony was held on Thursday, October 13 to celebrate the achievement of Purolite, an Ecolab company’s increased bioprocessing resin production to meet the growing demand for biopharmaceutical products globally.

Oct 19, 2022, 15:51 PM by

Creative Peptides announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand.

Oct 19, 2022, 15:51 PM by

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Oct 19, 2022, 15:51 PM by

BiologicsMD, a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced today the appointment of Brett King, MD, PhD, Associate Professor of Dermatology at Yale Medical School, as a Senior Scientific Advisor to the company’s management team and Board of Directors.

Oct 19, 2022, 15:51 PM by

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

Oct 19, 2022, 09:10 AM by

Oct 19, 2022, 09:09 AM by

Taking place on 17th November in London, Pharma Integrates is the must-attend event for leaders, strategists and innovators across pharma & healthcare looking to revolutionise modern medicine. An opportunity to make connections, discuss how to overcome market challenges and advance business goals.

Oct 19, 2022, 09:08 AM by

Innovative new technologies empower medical and biopharma scientists and researchers to extract greater insights from the transcriptome.

Oct 19, 2022, 09:07 AM by

– physIQ announced today that Jason Luke, MD, FACP, a recognized expert in immuno-oncology, professor of medicine, and clinical practitioner has been appointed to the company’s Medical Advisory Board. In this role, Dr. Luke will provide expert medical counsel for physIQ’s ongoing development of solutions to aide in oncology treatments, including physIQ’s development of digital biomarkers for inflammation.

Oct 19, 2022, 09:05 AM by

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials Risk-Based Quality Management: A front row seat to a decade of transformation

Oct 19, 2022, 01:00 AM by User Not Found

Bio-IT World | At the Bio-IT World Conference and Expo Europe yesterday, Richard Law, chief business officer for Exscientia, kicked off the event with an AI reality check. The term AI barely means anything anymore, he said, but he’s not the least bit soured on the possibility. We just need to shift our expectations.

Oct 18, 2022, 10:39 AM by

Exagen Inc. (Nasdaq: XGN), announced today that the company has appointed John Aballi as CEO and President. Longtime CEO and President Ron Rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.

Oct 18, 2022, 01:00 AM by User Not Found

Bio-IT World | The recent Illumina Genomics Forum occasioned the launch of several game-changing products, including the first FDA-regulated and CE-marked in vitro diagnostic high-throughput sequencer (NovaSeq 6000 Dx) and the company’s most powerful sequencer to date (NovaSeq X series) that can run 20,000 whole human genomes a year on a single instrument.

Oct 14, 2022, 01:00 AM by User Not Found

Bio-IT World | Oncology has been a shining example of the promise of precision medicine, and the tremendous gains to be made in human health when patients can be prescribed the right drug at the right time. But oncology has also shown the challenge of precision medicine: data interpretation. With each new source of data, the difficulty of making sense of the aggregated information only increases.

Oct 13, 2022, 09:45 AM by

InsightRX Offers Precision Dosing Support for New Drug Categories. New modules provide inpatient and outpatient dosing guidance for azole antifungals, solid organ transplant drugs, and inflammatory bowel disease biologics

Oct 13, 2022, 09:38 AM by

Maternova, Inc. announces the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.